Helixmith Rises 29.87% Amid Immune Checkpoint Inhibitor Theme Uptrend

On the 19th, the immuno-oncology theme showed strength by rising 3.07% compared to the previous day, with Helixmith, a related stock drawing attention, soaring 29.87% from the previous day. Helixmith is known as a company specializing in new drug development centered on gene therapy.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme

According to provisional data compiled at 12:41, foreigners are net buying 0.24 ten thousand shares of Helixmith.

[Table] Net Trading Volume of Foreigners and Institutions (Unit: Ten Thousand Shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Helixmith’s quant financial score is 0.56 points, ranking 21st in the quant financial ranking within the immuno-oncology theme. This can be interpreted as Helixmith having relatively low investment attractiveness from a financial perspective. On the other hand, Dong-A ST ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.